2m 2m 2m 2m 2m 2m 2m
CANDEL THERAPEUT (CADL)
NASDAQ
$8.93+$0.51 (+6.00%)
Price as of Jun 03, 2026 7:59 PM EDT- $608.1MMarket Cap
- 46.43%1-Year Change
- BiotechnologyIndustry
CANDEL THERAPEUT (CADL)
$8.93+$0.51 (+6.00%)
CADL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.42 | ||
Change | -$0.09 (-1.06%) | ||
Open | $8.52 | ||
High | $8.60 | ||
Low | $8.07 | ||
Previous Close | $8.51 | ||
Volume | 1,722,993 | ||
30-Day Average Volume | 2,256,037 | ||
1-Week Change | 5.91% | ||
1-Month Change | 30.14% | ||
1-Year Change | 46.43% | ||
3-Year Change | 450.33% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 73.3M | ||
Total Assets | $201.9M | ||
Market Cap | $608.1M | ||
Enterprise Value | $460.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$8.9M | ||
Free Cash Flow | -$18.7M | ||
EBIT | -$7.3M | ||
EBITDA | -$7.1M | ||
Net Working Capital | $190.7M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -64 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -59 | ||
PEG | -1 | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue